Notices. Notice
235 words·~1 min read·
/register/2011/11/25/2011-30326·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4120-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2011-N-0231] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Adverse Experience Reporting for Licensed Biological Products; and General Records AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is announcing that a collection of information entitled “Adverse Experience Reporting for Licensed Biological Products; and General Records” has been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850,
(301)796-7726, *ila.mizrachi@fda.hhs.gov* . SUPPLEMENTARY INFORMATION: On July 19, 2011, the Agency submitted a proposed collection of information entitled “Adverse Experience Reporting for Licensed Biological Products; and General Records” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0308. The approval expires on November 30, 2014. A copy of the supporting statement for this information collection is available on the Internet at *http://www.reginfo.gov/public/do/PRAMain.* Dated: November 18, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2011-30326 Filed 11-23-11; 8:45 am]
Connectionstraces to 1
Traces to 1 document